|
WO2013066438A2
(en)
|
2011-07-22 |
2013-05-10 |
President And Fellows Of Harvard College |
Evaluation and improvement of nuclease cleavage specificity
|
|
US20150044192A1
(en)
|
2013-08-09 |
2015-02-12 |
President And Fellows Of Harvard College |
Methods for identifying a target site of a cas9 nuclease
|
|
US9359599B2
(en)
|
2013-08-22 |
2016-06-07 |
President And Fellows Of Harvard College |
Engineered transcription activator-like effector (TALE) domains and uses thereof
|
|
US9388430B2
(en)
|
2013-09-06 |
2016-07-12 |
President And Fellows Of Harvard College |
Cas9-recombinase fusion proteins and uses thereof
|
|
US9340799B2
(en)
|
2013-09-06 |
2016-05-17 |
President And Fellows Of Harvard College |
MRNA-sensing switchable gRNAs
|
|
US9526784B2
(en)
|
2013-09-06 |
2016-12-27 |
President And Fellows Of Harvard College |
Delivery system for functional nucleases
|
|
US20150166984A1
(en)
|
2013-12-12 |
2015-06-18 |
President And Fellows Of Harvard College |
Methods for correcting alpha-antitrypsin point mutations
|
|
WO2016022363A2
(en)
|
2014-07-30 |
2016-02-11 |
President And Fellows Of Harvard College |
Cas9 proteins including ligand-dependent inteins
|
|
EP3025719B1
(en)
|
2014-11-26 |
2018-09-26 |
Miltenyi Biotec GmbH |
Combination immunotherapy of antigen-recognizing receptors and hematopoietic cells for the treatment of diseases
|
|
AU2016337525B2
(en)
|
2015-10-16 |
2022-01-20 |
The Trustees Of Columbia University In The City Of New York |
Compositions and methods for inhibition of lineage specific antigens
|
|
SG10202104041PA
(en)
|
2015-10-23 |
2021-06-29 |
Harvard College |
Nucleobase editors and uses thereof
|
|
EP3370741B1
(en)
*
|
2015-11-04 |
2025-10-08 |
The Trustees of the University of Pennsylvania |
Methods and compositions for gene editing in hematopoietic stem cells
|
|
HK1257668A1
(zh)
*
|
2016-02-19 |
2019-10-25 |
The Regents Of The University Of California |
短发夹rna(shrna734)及其用於阳性选择和消除遗传修饰的细胞的用途
|
|
KR20250103795A
(ko)
|
2016-08-03 |
2025-07-07 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
아데노신 핵염기 편집제 및 그의 용도
|
|
US11661590B2
(en)
|
2016-08-09 |
2023-05-30 |
President And Fellows Of Harvard College |
Programmable CAS9-recombinase fusion proteins and uses thereof
|
|
WO2018039438A1
(en)
|
2016-08-24 |
2018-03-01 |
President And Fellows Of Harvard College |
Incorporation of unnatural amino acids into proteins using base editing
|
|
SG11201903089RA
(en)
|
2016-10-14 |
2019-05-30 |
Harvard College |
Aav delivery of nucleobase editors
|
|
HUE067685T2
(hu)
*
|
2016-11-02 |
2024-11-28 |
Univ Basel |
Immunológiailag megkülönböztethetõ sejtfelszíni variánsok sejtterápiában történõ alkalmazásra
|
|
WO2018119359A1
(en)
|
2016-12-23 |
2018-06-28 |
President And Fellows Of Harvard College |
Editing of ccr5 receptor gene to protect against hiv infection
|
|
IL268895B2
(en)
*
|
2017-02-28 |
2025-05-01 |
Vor Biopharma Inc |
Compositions and methods for inhibition of lineage specific proteins
|
|
US11898179B2
(en)
|
2017-03-09 |
2024-02-13 |
President And Fellows Of Harvard College |
Suppression of pain by gene editing
|
|
EP3592381A1
(en)
|
2017-03-09 |
2020-01-15 |
President and Fellows of Harvard College |
Cancer vaccine
|
|
WO2018165629A1
(en)
|
2017-03-10 |
2018-09-13 |
President And Fellows Of Harvard College |
Cytosine to guanine base editor
|
|
WO2018176009A1
(en)
|
2017-03-23 |
2018-09-27 |
President And Fellows Of Harvard College |
Nucleobase editors comprising nucleic acid programmable dna binding proteins
|
|
WO2018209320A1
(en)
|
2017-05-12 |
2018-11-15 |
President And Fellows Of Harvard College |
Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation
|
|
CN111801345A
(zh)
|
2017-07-28 |
2020-10-20 |
哈佛大学的校长及成员们 |
使用噬菌体辅助连续进化(pace)的进化碱基编辑器的方法和组合物
|
|
EP3676376B1
(en)
|
2017-08-30 |
2025-01-15 |
President and Fellows of Harvard College |
High efficiency base editors comprising gam
|
|
US11795443B2
(en)
|
2017-10-16 |
2023-10-24 |
The Broad Institute, Inc. |
Uses of adenosine base editors
|
|
WO2019118949A1
(en)
|
2017-12-15 |
2019-06-20 |
The Broad Institute, Inc. |
Systems and methods for predicting repair outcomes in genetic engineering
|
|
EP3794130A4
(en)
|
2018-05-16 |
2022-07-27 |
Synthego Corporation |
METHODS AND SYSTEMS FOR DESIGNING AND USING GUIDE RNA
|
|
US12157760B2
(en)
|
2018-05-23 |
2024-12-03 |
The Broad Institute, Inc. |
Base editors and uses thereof
|
|
IL260445B
(en)
*
|
2018-07-05 |
2019-08-29 |
Lempo Therapeutics Ltd |
Methods and compositions for modulating myeloperoxidase (mpo) expression
|
|
EP3820495A4
(en)
|
2018-07-09 |
2022-07-20 |
The Broad Institute Inc. |
RNA-PROGRAMMABLE EPIGENETIC RNA MODIFIERS AND THEIR USES
|
|
WO2020047164A1
(en)
|
2018-08-28 |
2020-03-05 |
Vor Biopharma, Inc |
Genetically engineered hematopoietic stem cells and uses thereof
|
|
JP7716976B2
(ja)
*
|
2018-09-19 |
2025-08-01 |
フジフィルム セルラー ダイナミクス，インコーポレイテッド |
キメラ抗原受容体改変免疫細胞の活性化及び拡大培養のためのプロテインｌ
|
|
US12331320B2
(en)
|
2018-10-10 |
2025-06-17 |
The Research Foundation For The State University Of New York |
Genome edited cancer cell vaccines
|
|
WO2020092453A1
(en)
|
2018-10-29 |
2020-05-07 |
The Broad Institute, Inc. |
Nucleobase editors comprising geocas9 and uses thereof
|
|
CA3116412A1
(en)
*
|
2018-10-31 |
2020-05-07 |
Humanigen, Inc. |
Materials and methods for treating cancer
|
|
CN109852627B
(zh)
*
|
2018-12-26 |
2022-07-05 |
中国人民解放军军事科学院军事医学研究院 |
用于CRISPRi系统的质粒、其构建方法及其在使鼠疫菌目的基因定向沉默中的应用
|
|
AU2020207962A1
(en)
*
|
2019-01-18 |
2021-07-22 |
University Of Southern California |
Methods and compositions to improve the safety and efficacy of cellular therapies
|
|
US12351837B2
(en)
|
2019-01-23 |
2025-07-08 |
The Broad Institute, Inc. |
Supernegatively charged proteins and uses thereof
|
|
WO2020172638A1
(en)
*
|
2019-02-22 |
2020-08-27 |
The Trustees Of The University Of Pennsylvania |
Crispr/cas9 knock-out of cd33 in human hematopoietic stem/ progenitor cells for allogenic transplantation
|
|
EP4219700A1
(en)
*
|
2019-03-07 |
2023-08-02 |
The Regents of the University of California |
Crispr-cas effector polypeptides and methods of use thereof
|
|
EP3942043A2
(en)
|
2019-03-19 |
2022-01-26 |
The Broad Institute, Inc. |
Methods and compositions for editing nucleotide sequences
|
|
WO2020214842A1
(en)
|
2019-04-17 |
2020-10-22 |
The Broad Institute, Inc. |
Adenine base editors with reduced off-target effects
|
|
US20220333116A1
(en)
*
|
2019-08-28 |
2022-10-20 |
Vor Biopharma Inc. |
Compositions and methods for cd123 modification
|
|
WO2021041971A1
(en)
*
|
2019-08-28 |
2021-03-04 |
Vor Biopharma, Inc. |
Compositions and methods for cll1 modification
|
|
US12435330B2
(en)
|
2019-10-10 |
2025-10-07 |
The Broad Institute, Inc. |
Methods and compositions for prime editing RNA
|
|
AU2020361683A1
(en)
|
2019-10-11 |
2022-05-19 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for targeting CD13 and TIM-3 with CAR T cells to treat acute myeloid leukemia
|
|
KR102923195B1
(ko)
|
2020-02-28 |
2026-02-04 |
현대자동차주식회사 |
리튬이온 전지 음극 제조방법 및 이에 의해 제조된 리튬이온 전지 음극을 포함하는 리튬이온 전지
|
|
BR112022022603A2
(pt)
|
2020-05-08 |
2023-01-17 |
Broad Inst Inc |
Métodos e composições para edição simultânea de ambas as fitas de sequência alvo de nucleotídeos de fita dupla
|
|
EP3909612A1
(en)
*
|
2020-05-12 |
2021-11-17 |
Life Science Inkubator Betriebs GmbH & Co. KG |
Composition of nanoparticles
|
|
AU2021413252A1
(en)
*
|
2020-12-31 |
2023-06-08 |
Vor Biopharma Inc. |
Compositions and methods for cd34 gene modification
|
|
CN115443333B
(zh)
*
|
2021-04-27 |
2025-04-25 |
上海驯鹿生物技术有限公司 |
一种基因编辑的造血干细胞及其与car-t细胞的联合应用
|
|
CA3218208A1
(en)
*
|
2021-04-28 |
2022-11-03 |
Vinod VATHIPADIEKAL |
Antisense oligonucleotides and their use for treatment of neurodegenerative disorders
|
|
CA3236152A1
(en)
*
|
2021-11-09 |
2023-05-19 |
Vor Biopharma Inc. |
Compositions and methods for erm2 modification
|
|
EP4433512A4
(en)
|
2021-11-19 |
2025-12-31 |
Univ Pennsylvania |
Genetically modified pan-leukocyte-specific CD45 antigen to facilitate T-lymphocyte therapy
|
|
EP4463190A4
(en)
*
|
2022-01-11 |
2026-01-14 |
Actinium Pharmaceuticals Inc |
TREATMENT METHODS FOR CD33-POSITIVE HEMATOLOGICAL MALIGNITIES
|
|
WO2025030010A1
(en)
|
2023-08-01 |
2025-02-06 |
Vor Biopharma Inc. |
Compositions comprising genetically engineered hematopoietic stem cells and methods of use thereof
|
|
WO2025059062A1
(en)
*
|
2023-09-11 |
2025-03-20 |
The Trustees Of The University Of Pennsylvania |
Genetic engineering of human hematopoietic stem/progenitor cells (hspcs) for locus-specific expression of therapeutic proteins
|
